ReferenceID 5341
Geraniol exerts its antiproliferative action by modulating molecular targets in lung and skin carcinoma cells
Phytother Res
Geraniol, an acyclic monoterpene present in several plant species' essential oils, is utilized as a food additive. It possesses potent antiproliferative and antitumor effects ascribed to its antiinflammatory, and antioxi
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final reference record.
- Reference Id
- 5341
- Evidence Id
- 21931
- Core Evidence Id
- 21931
- Source Reference Id
- 3936
- Herb2 Reference Id
- HBREF004733
- Subject Paper Key
- HBIN027528_33826182
- Pubmed Id
- 33826182
- Doi
- 10.1002/ptr.7094
- Paper Title
- Geraniol exerts its antiproliferative action by modulating molecular targets in lung and skin carcinoma cells
- Paper Abstract
- Geraniol, an acyclic monoterpene present in several plant species' essential oils, is utilized as a food additive. It possesses potent antiproliferative and antitumor effects ascribed to its antiinflammatory, and antioxidant properties. The study aimed to understand geraniol's mechanism in human lung and skin cancer cells by employing molecular and cell target-based assays. SRB, NRU, MTT assays, qRT-PCR, molecular docking, and EAC model were used. Geraniol inhibits the proliferation of PC-3, A431, and A549 cells (~50%) and suppresses the activity of ornithine decarboxylase (15.42 +- 0.61 muM) and hyaluronidase (57.61 +- 8.53 muM) in A549 cells; LOX-5 (25.44 +- 3.50 muM) and hyaluronidase (90.71 +- 2.38 muM) in A431 cells. The qRT-expression analysis of the targeted gene depicts non-significant change at the transcriptional level of LOX-5 in A431 cells. A robust binding interaction of geraniol with molecular targets was observed in the molecular docking studies. In Ehrlich Ascites Carcinoma model, geraniol inhibit tumor growth by 50.08% at 75 mg/kg bw and was found to be safe up to 1,000 mg/kg bw in a toxicity study. Geraniol has two prenyl units allied head-to-tail and functionalized with one hydroxyl group at its tail end could be responsible for the antiproliferative activity. These observations provide evidence for geraniol to be used as a new prototype to develop a novel anticancer agent.
- Journal
- Phytother Res
- Publish Year
- 2021
- Experiment Subject
- human; a431 cells; a549 cells
- Experiment Type
- Cell Experiment
- Phenotype Related
- Lung And Skin Cancer; Tumor; Ehrlich Ascites Carcinoma
- Paper Title Cn
- Paper Title En
- Geraniol exerts its antiproliferative action by modulating molecular targets in lung and skin carcinoma cells
- Bilingual Status
- semi_complete